Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Moderna, Inc. Director's Dealing 2020

Jun 25, 2020

30610_dirs_2020-06-25_f3d4b11b-c91b-44c1-b73d-5373a59461c8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-06-23

Reporting Person: Hoge Stephen (President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-06-23 Common Stock S 3009 $63.34 Disposed 1983531 Direct
2020-06-23 Common Stock S 1891 $64.19 Disposed 1981640 Direct
2020-06-23 Common Stock S 100 $64.95 Disposed 1981540 Direct
2020-06-24 Common Stock S 2205 $64.33 Disposed 1979335 Direct
2020-06-24 Common Stock S 2595 $65.11 Disposed 1976740 Direct
2020-06-24 Common Stock S 200 $65.84 Disposed 1976540 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 4116 Indirect

Footnotes

F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.86 to $63.81. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.87 to $64.81. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.70 to $64.70. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.72 to $65.54. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.78 to $65.90. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.